Press ReleasesKanabo Launches Ecommerce Platform To Help Improve Wellbeing Of...

Kanabo Launches Ecommerce Platform To Help Improve Wellbeing Of Millions Of People

-

KANABO, the UK medicinal cannabis company focusing on the development and distribution of cannabis-derived products for medical patients, is launching its eCommerce platform for wellness CBD consumers.

The Kanabo.store will cater to the UK market initially and then roll out across Europe, giving CBD consumers access to Kanabo’s three proprietary CBD formula pods that work with Kanabo’s unique VapePod, the first of its kind medical grade vaporiser that provides easy-to-use metered dosing.

Relax helps you quiet your mind and find your inner tranquility with a calming blend of CBD and carefully chosen terpenes, Reload resets your clarity and focus with a stimulating blend of CBD and reinvigorating terpenes while Repair helps release your tension, regain your balance and get back on track with a powerful blend of CBD, CBG and carefully selected terpenes.

The world renowned R&D team at Kanabo, the first medicinal cannabis company to IPO on the London Stock Exchange, has made the VapePod a real game changer as it gives a metered dose of 1mg on every inhalation, so consumers know the exact amount consumed – and exactly what it is they are inhaling.

Thanks to the rapid onset of cannabinoids delivered to the body by simply inhaling, the VapePod offers the shortest delivery time with noticeable effects via the pulmonary tract. The device cuts out as soon as it reads that 1mg of CBD has been inhaled. The VapePod’s bioavailability is higher compared to other delivery methods as the body does not flush out a lot of the product as it can do with capsules or tinctures.

The CBD Pods are manufactured in the UK and the portable and easy to use VapePod is discreet for social or work settings. Each CBD Pod contains 300 doses per unit and the hemp from which our broad spectrum CBD is made contains minor cannabinoids and hemp terpenes that are naturally sourced and are manufactured at an EU-GMP facility, meeting the highest production standards worldwide. Kanabo’s CBD formulas boast a huge 80% cannabinoids (360 mg of CBD) and are made with only pure hemp ingredients; 100% vegan and without any commonly added diluents such as harmful PG, VG, MCT or PEG oils.

Avihu Tamir, founder and CEO of Kanabo, said: “Our VapePod is a game-changer for CBD consumers who aim to improve their health and quality of life.

“No other CBD delivery system currently on the market offers the same precise, metered dosing solution that the VapePod consistently provides. We use the highest quality hemp-derived natural ingredients which makes the VapePod the most effective CBD delivery system in the world.”

The VapePod can also be used for medicinal cannabis as it allows physicians to now confidently prescribe accurate and precise micro doses of cannabis and collect accurate patient data.

Latest news

British People Open To Using Medical Cannabis – Yet Majority Unaware They Can Access It On Prescription 

A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine.  Key...

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint the European industry will continue to grow, say the continent’s...

Chrystal Capital Acts As Exclusive Advisor To Change Agronomy On £9.6m Fundraise

CHRYSTAL Capital Partners LLP, is an entrepreneurial corporate finance and investment house with an established global network of Single...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s...

Business of Cannabis Conference Returns to New York City on November 3rd

In this second summit, the most influential business leaders, investors and politicians gather to discuss social equity, policy and...

Curaleaf Takes Majority Stake And Forms Strategic Partnership With Germany’s Four 20 Pharma In €20m Deal

CURALEAF Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading U.S. provider of consumer products in cannabis, announced that Curaleaf International...

Must read

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of...

You might also likeRELATED
Recommended to you